Immune Cell Profiling Reveals a Common Pattern in Premetastatic Niche Formation Across Various Cancer Types
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified common immune cell changes during cancer metastasis across different cancer types. These findings enable prediction of metastatic phases and early cancer detection, independent of cancer type.
Area Of Science
- Immunology
- Oncology
- Bioinformatics
Background
- Cancer metastasis is a leading cause of cancer mortality.
- The premetastatic niche is a critical but poorly understood factor in metastasis.
- Understanding premetastatic niche formation is key to developing preventative strategies.
Purpose Of The Study
- To investigate the generality and cellular dynamics of premetastatic niche formation.
- To identify common immune cell alterations across different cancer types during metastasis.
- To develop predictive models for metastatic phases.
Main Methods
- Comprehensive flow cytometric analysis of lung and peripheral immune cells.
- Analysis across three distinct phases: early premetastatic, late premetastatic, and micrometastatic.
- Application of machine learning to immuno-cell profiles for metastatic phase prediction.
Main Results
- A consistent pattern of immune cell profile changes was observed across breast cancer, lung cancer, and melanoma models.
- Key changes include decreased eosinophils (early), increased regulatory T cells (late), and altered polymorphonuclear myeloid-derived suppressor cells and B cells (micrometastatic).
- Machine learning models predicted the metastatic phase with approximately 75% accuracy based on immune cell profiles.
Conclusions
- The study reveals generalities in premetastatic niche formation applicable across cancer types.
- These findings provide a foundation for developing cancer type-independent methods for early detection and prevention of metastasis.
- Further validation in human studies and exploration of additional biomarkers (proteins, EVs, nucleic acids, metabolites) are recommended for enhanced prediction.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
